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 50 
Abstract 51 
 52 
 Receptor-activator of nuclear factor kB (RANK), its ligand RANKL and the soluble decoy 53 
receptor osteoprotegerin (OPG) are the key regulators of osteoclast differentiation and bone 54 
remodeling. Here we show that RANK is also expressed in fully differentiated myotubes and 55 
skeletal muscle. Muscle RANK deletion (RANKmko) has inotropic effects in denervated, but 56 
not in sham, extensor digitorum longus (EDL) muscles preventing the loss of maximum 57 
specific force while promoting muscle atrophy, fatigability and increased proportion of fast-58 
twitch fibers. In denervated EDL muscles, RANK deletion markedly increased stromal 59 
interaction molecule 1 (Stim1) content, a calcium sensor, and altered activity of the 60 
sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) modulating Ca2+ storage. Muscle 61 
RANK deletion had no significant effects on the sham or denervated slow-twitch soleus (Sol) 62 
muscles. These data identify a novel role for RANK as a key regulator of calcium storage and 63 
SERCA activity, ultimately affecting denervated skeletal muscle function. 64 
 65 
 66 
 67 
 68 
  69 
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Introduction 70 
 Receptor-activator of nuclear factor kB ligand (RANKL), the membrane receptor RANK 71 
and the soluble decoy receptor osteoprotegerin (OPG) are members of the tumor necrosis 72 
factor (TNF) superfamily that regulate bone remodelling (26, 29). RANK/RANKL 73 
interaction activates Ca2+-dependent and NF-kB signalling pathways, which affect osteoclast 74 
differentiation, activation and survival (29). The third protagonist, OPG, binds to RANKL 75 
and inhibits the RANK/RANKL interaction and subsequent osteoclastogenesis (46, 55). In 76 
addition to bone, RANK/RANKL has been detected in other tissues such as thymus, heart, 77 
kidney, liver, brain, blood vessels and skeletal muscles (17, 32, 51). The RANK/RANKL 78 
pathway is known to be involved in a variety of physiological and pathological conditions 79 
such as lymph-node organogenesis, formation of lactating mammary gland, breast cancer, 80 
central thermoregulation, T-cell/dendritic cell communication, vascular calcification, and 81 
bone metastasis (18, 36, 38, 41, 45). 82 
 83 
 Muscle hypertrophy/atrophy and gain/loss of bone mineral density occur in parallel in 84 
many physiological or pathological conditions and endocrine, mechanical factors, 85 
inflammatory and nutritional states affect simultaneously skeletal muscle and bone 86 
metabolism (3, 4, 16, 22, 39). These observations are consistent with the view that skeletal 87 
muscle and bone share common cell signalling pathways. For example, the Wnt/β-catenin 88 
signalling pathway is a major regulator of bone mass and muscle development and growth 89 
(24). Conditional deletion of Ctnnb1 gene in osteocytes, which encodes for β-catenin, leads 90 
to impaired bone maturation and mineralization with increased RANKL:OPG ratio (27). In 91 
bone, RANKL/RANK interactions activate tumour necrosis factor receptor-associated factors 92 
6 (TRAF-6), which subsequently induces the activation of downstream signalling molecules 93 
and intracellular calcium concentration ([Ca2+]i) oscillations (53). The ATP-dependent Ca2+ 94 
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pump, sarco(endo)plasmic reticulum Ca2+ATPase (SERCA), is essential for [Ca2+]i 95 
oscillations and plays a critical role in osteoclastogenesis (54). Moreover, it has been shown 96 
that TRAF-6 is required for functional bone resorption and muscle-specific TRAF-6 deletion 97 
preserves function and reduces atrophy in a model of muscle wasting indicating that TRAF-6 98 
is an important regulator of both bone and muscle masses (19, 49, 50). Thus, common 99 
signalling pathways are emerging to explain the synchronicity between bone and skeletal 100 
muscle physiology and pathophysiology. 101 
 102 
 Muscle contraction involves the depolarization of the transverse-tubular (t) system, which 103 
activates dihydropyridine receptors (DHPRs) opening ryanodine receptor/Ca2+ release 104 
channels (RYR1) in the sarcoplasmic reticulum (SR) membrane. This results in the rapid 105 
influx of Ca2+ into the cytoplasm through RYR1 and binding of Ca2+ ions to troponin C 106 
causing the formation of actin-myosin cross-bridges and force development (34). Calcium 107 
reuptake in the SR is a tightly control mechanism mediated almost exclusively by SERCA-1a 108 
in fast-twitch fibers and SERCA-2a in slow-twitch fibers. The regulation of Ca2+ is also 109 
implicated in other physiological processes such as the maintenance and adaptation of muscle 110 
phenotypes (7, 40), while chronic rise in [Ca2+]i is associated with different pathological 111 
states including muscle dystrophy (1) and the triggering of apoptotic processes (12, 42). 112 
Therefore, the appropriate regulation of [Ca2+]i is a requirement for proper cell function, 113 
phenotype and survival. 114 
 115 
 We recently reported that OPG treatments protect against muscular dystrophy suggesting a 116 
potential role for RANK/RANKL/OPG pathway in muscle disease. In addition, muscle 117 
specific TRAF-6 deletion prevented muscle atrophy and decreased the expression of 118 
ubiquitin-proteasome components in models of denervation or starvation (28, 50). In the 119 
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present study, we hypothesized that muscle RANK, a receptor upstream of TRAF-6, is an 120 
important regulator of denervated muscle function. We report that RANK/RANKL regulates 121 
Ca2+ storage, function and phenotype, confirming a role for RANK in denervated skeletal 122 
muscles.  123 
  124 
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Material & Methods 125 
 126 
Ethical Approval: All procedures were approved by the Université Laval Research Center 127 
Animal Care and Use Committee based on Canadian Council on Animal Care guidelines. 128 
 129 
Animals: Mice carrying the RANKfloxed or RANKdel alleles and muscle creatine kinase-Cre 130 
(mck-Cre) mice were backcrossed five times to a C57BL/10J background before generating a 131 
specific RANK skeletal muscle deletion, the mck-Cre RANKdel/floxed, hereafter named 132 
Rankmko mice (18). RANKmko mice are viable, healthy and appeared indistinguishable from 133 
control RANKfloxed/floxed mice that do not carry the Cre recombinase, hereafter named 134 
RANKf/f mice. Male wild-type (C57BL/10J) mice were purchased from the Jackson 135 
Laboratory and bred at our animal facility. Mice were screened for the desired genotype by 136 
PCR analysis. Food and water were provided ad libitum. At the end of the different 137 
experimental procedures, the mice were euthanized by cervical dislocation under anaesthesia. 138 
 139 
Denervation: Sciatic denervation was performed under anaesthesia with isoflurane 140 
inhalation on adult mice aged between 12-18 weeks. Briefly, the hindlimbs were shaved and 141 
a small 0.5-cm incision was made proximal to the hip on the lateral side of the leg to expose 142 
and section a 3-5 mm piece of the sciatic nerve. The wounds were then closed with surgical 143 
sutures. The same surgery procedures were executed without sciatic denervation for sham 144 
mice. Mice were euthanized 14 days after sham or denervation procedures. Animals without 145 
chirurgical procedures were used as control mice.  146 
 147 
Cell culture: C2C12 myoblasts (ATCC) were cultured in high glucose DMEM (HyClone) 148 
supplemented with 10% FBS (HyClone) and 1% antibiotic-antimycotic (Life Technologies) 149 
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in 5% CO2 and at 37°C. When the myoblasts reached 90% confluence, the medium was 150 
replaced by high glucose DMEM containing 1% FBS for 5 days to allow the myoblasts to 151 
differentiate into myotubes (11).  152 
 153 
Genomic DNA for genotyping: Genomic DNA from mouse tail tissue samples was isolated 154 
and amplified by PCR. RANK, cre, and dystrophin was identified by isolating genomic DNA 155 
from tail tissue and screening for the mutation or presence of the transgene by PCR. To detect 156 
delta, flox and wild-type alleles primers used were p87, p88 and p105. Conditions : 94 oC 2 157 
min, 40 cycles of (94 oC 30 s, 60 oC 20 s, 72 oC 1 min) and 72 oC 4 min. To detect the 158 
presence of the mck-cre primers used were ALP 130  and ALP 131. Conditions : 94 oC 2 min, 159 
40 cycles of (94 oC 30 s, 58 oC 10 s, 72 oC 1 min) and 72 oC 4 min. To detect mdx allele 160 
primers used were p9427 and p259E. Conditions : 94 oC 3 min, 45 cycles of (94 oC 30 s, 57 161 
oC 30 s, 72 oC 20 s) and 72 oC 10 min. 162 
Isometric contractile properties: Mice were injected with buprenorphine (i.p. 0.1 mg/kg) 163 
and anesthetised with pentobarbital sodium (i.p. 50 mg/kg) 15 min later. Mice were weighed 164 
and the soleus (Sol) and extensor digitorum longus (EDL) muscles were carefully dissected, 165 
attached to an electrode and a force sensor (305B-LR, Aurora Scientific, Inc.) to assess 166 
contractile properties as described previously (9, 44). Muscle fatigability was examined by 167 
stimulating muscle for 200 ms every second at 50 Hz until muscles lost 30% (Sol) or 50% 168 
(EDL) of their initial force. Lastly, muscle length was measured, tendons were removed and 169 
muscles weighed for calculation of muscle cross-sectional area and specific force (13). 170 
Functional measurements were analyzed with the Dynamic Muscle Data Analysis software 171 
(Aurora Scientific, Inc.).  172 
 173 
Immunohistochemistry: Transversal Sol and EDL muscle sections (10 µm) were cut (Leica 174 
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Microsystems CM1850, Nussloch, Germany) in duplicate from the proximal and distal 175 
portions of the muscles. Sections were incubated overnight at 4oC with the following primary 176 
antibodies: anti-SERCA1a (Abcam), anti-SERCA2a (Abcam), anti-MyHC I (Novus 177 
Biological), anti-MyHC IIA (SC-71, DSHB), anti-MyHC IIB (BF-F3, DSHB), anti-MyHC 178 
IIX (6H1, DSHB), anti-dystrophin (NCL-Dys1, Vector Laboratories) and anti-RANK (R&D 179 
Systems). Pan-MyHC II was obtained by combining three antibodies: anti-MyHC IIA, anti-180 
MyHC IIB and anti-MyHC IIX (DSHB). Fiber-type differentiation by myosin 181 
immunohistochemical was performed as described by Schiaffino et al. (43). Biotinylated 182 
secondary antibodies for immunohistochemistry were purchased from Vector Laboratories 183 
and Alexa Fluor® secondary antibodies from Invitrogen. The localization of RANK and 184 
dystrophin in the sarcolemmal membrane of skeletal muscles was determined by confocal 185 
microscopy. Briefly, confocal series were acquired using a Quorum WaveFX spinning disc 186 
confocal system (Quorum Technologies, Guleph, Ontario) with 491 nm and 561 nm solid 187 
state laser lines for excitation of green and red (Alexa-488 and Alexa-594), combined with 188 
appropriate BrightLine single-bandpass emission filters (536/40 nm and 624/40 nm, 189 
Semrock). For DAPI visualization, wide-field z-series were acquired at the same time with a 190 
DAPI fluorescence filter cube (Chroma Technology). The CCD camera used to capture the 191 
images was a Hamamatsu ImagEM C-9100. 192 
 193 
Western blotting: Myotubes or skeletal muscles were homogenized in a lysis buffer 194 
containing 10 μl of protease inhibitor cocktail (Sigma-Aldrich). Protein homogenates were 195 
electrophoretically separated on SDS-polyacrylamide gels and transferred to polyvinylidene 196 
difluoride membranes (PVDF; Bio-Rad), blocked in 5% skim milk and incubated overnight 197 
at 4°C. The following primary antibodies (all from Santa Cruz Biotechnology) were used: 198 
anti-SERCA-1a, anti-SERCA-2a, anti-Stim1, anti-calsequestrin, and anti-RANK anti-199 
 10
GAPDH. The membranes were washed and incubated with appropriate HRP-conjugated 200 
secondary antibodies (Santa Cruz Biotechnology). Protein bands were revealed using the 201 
ECL-Plus chemiluminescent detection system (Perkin-Elmer). Films (Denville scientific inc.) 202 
were used to detect a chemiluminescent signal, scanned, and analyzed using Quantity One 203 
software (v4.6.6, Bio-Rad) (10). 204 
Calcium measurements: In another set of experiments, the concentration of total Ca2+ in Sol 205 
and EDL muscles was determined using the Ca2+-dependent UV absorbance of 1,2-Bis (2-206 
Aminophenoxy) ethane-N,N,N’,N’-tetraacetic acid (BAPTA) which is a good estimate of 207 
[CaT] in the SR (30). Briefly, whole Sol and EDL muscles from 12 week-old mice were 208 
weighed and homogenized in a solution containing 0.3 mM BAPTA and sodium dodecyl 209 
sulphate (SDS) detergent to dissolve the surface and SR membranes. The mixture was then 210 
centrifuged removing proteins and other insoluble muscle components to prevent unwanted 211 
absorbance or light scattering. To determine the amount of total Ca2+, the supernatant was 212 
divided into four aliquots for separate absorbance measurements taken at 292 nm: 1) the 213 
supernatant alone; 2) The UV absorbance spectrum (240-390 nm) of the supernatant plus 1 214 
mM EGTA added to give a zero Ca2+ BAPTA spectrum; 3) the supernatant with a known 215 
amount of Ca2+ standard added; and 4) the supernatant with excess Ca2+ added to complex 216 
essentially all of the binding sites on BAPTA with Ca2+. From the absorbance data and the 217 
equations given by Lamboley et al. (30), values of total Ca2+ concentration were estimated 218 
and reported here in units of mmoles/kg muscle weight. [CaT] measurements include the 219 
following components: extracellular ([CaT]EC), intracellular outside of the SR ([CaT]NonSR), 220 
and intracellular inside the SR ([CaT]SR). The Ca2+ chelator, BAPTA, should provide the best 221 
estimate of [CaT]SR under physiological conditions (30). 222 
 223 
SERCA parameters: Homogenates from the muscles of WT and KO mice were used to 224 
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determine Ca2+ dependent Ca2+-ATPase activity using a spectrophotometric assay 225 
(SPECTRAmax Plus; Molecular Devices) (47). Briefly, reaction buffer (200 mM KCl, 20 226 
mM HEPES (pH 7.0), 15 mM MgCl2, 1 mM EGTA, 10 mM NaN3, 5 mM ATP and 10 mM 227 
PEP) containing 18 U/mL of both LDH and PK, as well as the homogenate were added to test 228 
tubes containing 15 different concentrations of Ca2+, ranging between 7.6 and 4.7 pCa units 229 
in the presence and absence of ionophore A23187 (4.2 μM). In the absence of the ionophore, 230 
Ca2+ accumulates inside the SR vesicle and causes back-inhibition of SERCA pumps, which 231 
is more relevant to the physiological system found in skeletal muscle. Aliquots (100 μl) were 232 
then transferred in duplicate to a clear bottom 96-well plate (Costar, Corning Incorporated, 233 
NY), where 0.3 mM NADH was added to start the reaction. The plate was read at a 234 
wavelength of 340 nm for 30 min at 37°C. The different concentrations of Ca2+ in the wells 235 
were used to determine the maximal enzyme activity (Vmax) and pCa50, which is defined as 236 
the [Ca2+]f required to achieve 50% of Vmax. Lastly, cyclopiazonic acid (CPA; 40 μM), a 237 
highly specific SERCA inhibitor, was used to determine background activity which was 238 
subtracted from the total Ca2+-ATPase activity measured in muscle homogenate. All data 239 
were then plotted against the negative logarithm of [Ca2+]f (pCa) using basic statistatical 240 
software (GraphPad PrismTM version 4) to determine Vmax and pCa50. pCa50 was 241 
determined by non-linear regression curve fitting using the sigmoidal dose response. 242 
 243 
Statistical analyses. All values are expressed as means ± SEM. The data were analyzed with 244 
Student’s t-test, Chi-square test or one-way ANOVA followed by a Tukey’s test (InStat). The 245 
levels of significance were set at * p<0.05, ** p<0.01, *** p<0.001 for genotype (RANKf/f vs 246 
RANKmko) or # p<0.05 for treatment (Sham vs Den). 247 
 248 
 249 
250 
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Results 251 
RANK is expressed in fully differentiated C2C12 myotubes and at the sarcolemmal 252 
membrane of skeletal muscle 253 
 To assess RANK expression in muscle cells, we first analysed its expression in C2C12 254 
myoblasts and differentiated myotubes. RANK was found to be expressed in C2C12 255 
myotubes but not in proliferating C2C12 myoblasts (Fig. 1a). We next analysed RANK 256 
expression in skeletal muscle cells in situ using confocal microscopy. Confocal 257 
immunofluorescence confirmed the presence of RANK protein on the membrane of fast-258 
twitch (EDL) (Fig. 1b) and slow-twitch (Sol; data not shown) skeletal muscle fibers. To 259 
confirm specific RANK expression in muscle, we crossed RANKf/f mice onto a muscle 260 
creatine kinase-Cre background to generate muscle-specific RANK knockout mice (RANKmko 261 
mice). PCR results validated the deletion of the RANK allele specifically in skeletal muscle 262 
tissue and partially in heart (Fig. 1c). Deletion efficiency was confirmed at the protein level 263 
in skeletal muscles where RANK immunostaining was not detectable (Fig. 1b).  264 
 265 
RANK deletion affects denervated muscle mass and function 266 
 To examine the role of RANK/RANKL in muscle pathophysiology, muscle mass, 267 
contractile properties and fiber type proportions were examined in sham and denervated Sol 268 
and EDL muscles from RANKf/f and RANKmko mice. Denervation and/or RANK deletion did 269 
not influence mouse body weight. Treatment, but not genotype, reduced EDL and Sol muscle 270 
masses when normalized to body weights (Table 1). Intriguingly, denervated EDL muscles 271 
from RANKmko mice exhibited inotropic effects as determined by the decrease in muscle mass 272 
(Fig. 2a), combined with the partial preservation of maximum specific force (sP0 ; N/cm2) 273 
compared to denervated RANKf/f muscles (Fig. 2b). The absolute force production (P0; g) was 274 
not different between RANKf/f and RANKmko EDL muscle but RANK deletion prevented the 275 
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loss of twitch tension (Pt) in denervated EDL muscles (Table 2). The contractile properties of 276 
control mice were similar between both genotypes (Table 2). Lastly, the Pt/P0 ratio was 277 
increased in both Sol and EDL muscles of denervated RANKmko mice (Fig. 2c), suggesting a 278 
change in myofilament Ca2+ sensitivity and/or SR Ca2+ release. 279 
 280 
 Denervation led to decreased fatigue resistance in both Sol and EDL muscles during a 281 
repetitive and glycolytic fatigue protocol (Fig. 2d,e). Both sham and denervated RANKmko 282 
EDL muscles exhibited increased fatigability compared to sham and denervated RANKf/f 283 
muscles (Fig. 2d,e). In accordance with the higher fatigability, immunohistochemical fiber 284 
typing showed that the slow-twitch fibers were nearly absent in sham RANKmko EDL muscles 285 
while the proportion of fast-twitch fibers (IIA+IIX+IIB) was significantly increased in 286 
denervated RANKmko EDL muscles compared to denervated RANKf/f EDL muscles (Fig. 2f). 287 
The proportion of fiber type over 100% in denervated RANKmko EDL muscles indicated the 288 
presence of hybrid fibers expressing multiple isoforms of MyHC. No changes in muscle fiber 289 
type were observed in Sol muscles (Fig. 3a) indicating that the impact of muscle RANK 290 
deletion on muscle fatigue and phenotype is limited to fast-twitch EDL muscles. Noticeably, 291 
the proportion of fast-twitch fibers expressing SERCA-1a was reduced and the proportion of 292 
fast-twitch fibers expressing SERCA-2a was increased in RANKmko Sol and EDL muscles 293 
(Fig 3b).  294 
 295 
Total calcium and SERCA activity and expression in RANK f/f and RANKmko muscles  296 
 Our recent published data show an inverse relationship between [CaT] and muscle mass, 297 
where the highest values of [CaT] are seen with the lowest muscle weights (30). Since 298 
RANK deletion promotes muscle atrophy and prevents force deficits in denervated muscles, 299 
we next measured [CaT] in EDL muscles (Fig. 4a-c). Despite similar muscle masses, the 300 
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average values of [CaT] were 42% lower in sham RANKmko relative to sham RANKf/f  EDL 301 
muscles (Fig. 4c), indicating that under non pathological conditions muscle RANK is 302 
important in Ca2+ storage of skeletal muscles. Consistent with the observed inverted 303 
relationship between [CaT] and muscle weights, we found that muscle weights below <4.5 304 
mg had much greater [CaT] than the bigger muscles, but data were non-linear due to a floor 305 
effect in the assay (Fig. 4b). Consistent with the reduced muscle mass in denervated RANKmko 306 
EDL muscles (Fig. 2a), [CaT] increased by 93% in denervated RANKmko EDL muscles while 307 
it did not significantly increase in denervated RANKf/f EDL muscles (Fig. 4c).  308 
 309 
 Since SERCA is critical for Ca2+ cycling in the SR, we analyzed SERCA1a and SERCA2a 310 
expression and SERCA activity in Sol and EDL muscle extracts. Western blotting analyses 311 
show that SERCA1a content is significantly reduced in denervated muscles while SERCA2a 312 
content is significantly increased following denervation, independently of the genotype (Fig 313 
4d). No difference in calsequestrin content, a calcium binding protein located in SR, was 314 
observed between RANKf/f and RANKmko muscles (Fig 4d). However, the content of the 315 
stromal interaction molecule 1 (Stim1), which functions as a calcium sensor in the SR, 316 
increased by 77% and 411% in denervated RANKf/f and RANKmko EDL muscles, relative to 317 
their respective sham (Fig 4d). The concentration of Stim1 increased significantly by 184% 318 
in denervated RANKmko compared to denervated RANKmko EDL muscles. Next, we assessed 319 
SERCA Ca2+-dependent ATPase activity in muscle homogenates from sham and denervated 320 
RANKf/f and RANKmko Sol and EDL muscles over Ca2+ concentrations ranging from pCa 7.0 321 
to pCa 4.5. Interestingly, upon denervation, maximal SERCA activity was reduced in both 322 
the Sol and EDL muscles (Fig. 4e-g and Fig. 5). Moreover, maximal SERCA activity was 323 
significantly reduced in both the sham and denervated RANKmko EDL compared to the sham 324 
and denervated RANKf/f EDL (Fig. 4c-f). This inhibitory effect of RANK deletion on SERCA 325 
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activity was limited to EDL muscles and did not affect Sol muscles. Overall, these findings 326 
demonstrate a direct role for muscle RANK in the regulation of SERCA activity and Stim1 327 
content in fast-twitch EDL muscles. 328 
 329 
 330 
  331 
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Discussion 332 
 We previously demonstrated that systemic injection of OPG, the decoy receptor of 333 
RANKL, restores muscle force and improves muscle histology in dystrophic mdx mice (9). 334 
However, whether the RANK/RANKL/OPG system directly or indirectly affects skeletal 335 
muscle was unknown. In this paper, using muscle specific RANK mutant mice, we 336 
demonstrate that RANK is expressed in skeletal muscle cells where it directly regulates 337 
muscle function. Importantly, muscle-specific RANK deletion protects from denervation-338 
induced loss of muscle force and modulates total Ca2+ storage and SERCA activity.  339 
 340 
 RANK is well characterized in osteoclasts where it leads to the activation of different 341 
signalling pathways, especially NF-kB and calcium-dependent pathways (5). In skeletal 342 
muscle, Ca2+ is a master regulator of multiple intracellular processes such as myosin-actin 343 
cross-bridging, protein synthesis and degradation, mitochondrial adaptation and fiber type 344 
shifting, through the control of Ca2+ sensitive proteases and transcriptional factors such as 345 
NFATc1 (2). Consistent with a role of RANK in the regulation of calcium handling, 346 
conditional deletion of RANK in skeletal muscle affected muscle contraction post-347 
denervation, atrophy and fiber type, all of which are regulated by Ca2+ (2). Intriguingly, 348 
muscle-specific RANK deletion prevents the loss of specific force production but not the loss 349 
of muscle mass following denervation. Without significant changes in muscle mass, muscle 350 
strength can be altered by (1) the amplitude or duration of the Ca2+ transient or (2) the 351 
sensitivity of the myofilaments to Ca2+. For instance, reduced force production in aged 352 
muscle is partially caused by reduced Ca2+ content and myofilament sensitivity (31). Our 353 
findings show that RANKmko denervated muscles have higher [CaT], which originates from 354 
increased intracellular calcium stocks (30, 33). Therefore, higher Ca2+ content potentially 355 
results in greater rates of Ca2+ release, increased myoplasmic Ca2+ transients, and, ultimately, 356 
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preserved muscle force production. These results are supported by the increased specific 357 
force and Pt/P0 ratio in denervated RANKmko EDL muscle, indicating that these muscles are 358 
able to generate a stronger contraction following submaximal stimulation.  359 
 360 
 The higher releasable Ca2+ content is not explained by greater SERCA activity since we 361 
found that denervated RANKmko muscles had low SERCA activity rate compared to the 362 
denervated RANKf/f . Moreover, we observed no change in CSQ content making it unlikely to 363 
explain the greater releasable Ca2+ content; however, in the normal EDL muscles it was 364 
shown that the resting SR Ca2+ content is only a relatively small proportion of its maximal 365 
content and that Ca2+ bound to CSQ is only one-third of its saturated level (14, 35, 52). Thus, 366 
it is likely that the increase in [CaT] observed in the denervated RANKmko EDL reflects an 367 
increased binding of Ca2+ in the SR thereby increasing releasable SR Ca2+ and ultimately 368 
specific force production. In this respect, the relatively greater inhibition of SERCA activity 369 
may serve to prolong the Ca2+ transient and increase force production, while decreasing the 370 
fatigue resistance. Accordingly, we observed higher muscle strength following a single 371 
contraction (Pt) in denervated RANKmko EDL muscle combined with increased fatigability 372 
following repeated maximal contractions. The exact mechanisms lowering SERCA activity in 373 
response to RANK deletion are unknown and require further investigation – and analysis of 374 
sarcolipin and phospholamban, two well-known regulators of the SERCA pump (15), 375 
indicate increased expression of both proteins in response to denervation, however no 376 
significant differences were found between genotype (data not shown).   377 
 378 
 Enhanced Ca2+ entry could be responsible for any increase in SR Ca2+ content in muscle. 379 
In osteoclasts, RANKL-mediated Ca2+ entry could arise from intracellular or extracellular 380 
origin (6, 25). Members of the transient receptor potential vanilloid channels (TRPV) family, 381 
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TRPV2 and TRPV5, were demonstrated to mediate RANKL-induced calcium entry (6, 23). 382 
Store-operated calcium entry (SOCE) channels, that sense declining Ca2+ ion concentration in 383 
the SR, were also associated with RANKL-induced calcium entry (23). For instance, 384 
silencing of the SOCE channel Orai1 with specific shRNA inhibits RANKL-induced 385 
osteoclastogenesis by suppressing NFATc1 induction (20). Mice lacking SOCE specifically 386 
in skeletal muscle exhibit reduced muscle mass and increased susceptibility to fatigue 387 
whereas Stim1-/- myotubes failed to refill their stores and altered expression of key SR 388 
proteins (48). Furthermore, the use of SERCA inhibitor suggests that under some conditions 389 
the role of SERCA in replenishing Ca2+ stores is limited (37). Our current findings that 390 
denervation treatment and RANK deletion markedly increased Stim1 content (184%) may 391 
explain, in part, the discrepancy between the rise in [CaT] and the depression of SERCA 392 
activity in denervated RANKmko EDL muscles. It is thus tempting to speculate that SOCE 393 
would compensate for the lack of SERCA activity in denervated RANKmko EDL muscles. 394 
The mechanisms by which RANKL/RANK controls Ca2+ storage in skeletal muscle cells 395 
requires further experiments, nevertheless our findings provide the first evidence that RANK 396 
is a novel regulator of Ca2+ storage in skeletal muscle cells.  397 
 398 
  With respect to EDL muscle fatigability, we found that both denervation and RANK 399 
deletion led to higher fatigability than their wild type and sham-operated counterparts. 400 
Consistent with this observation, we found that RANKmko muscles increased the number of 401 
fast-twitch type II fibers; however, the disproportionate increase of fatigability in RANKmko 402 
muscle compared to the relatively modest changes in fiber type and that no changes on 403 
muscle contractility, fatigue and phenotype were observed in Sol muscles, suggests that the 404 
muscle fiber type phenotype may not be the main reason to explain the fatigue in RANKmko 405 
muscle. Indeed, the decreased fatigue resistance observed following denervation was 406 
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associated with an increased proportion of type I fibres in both RANKf/f and RANKmko Sol and 407 
EDL muscles. It could be speculated that the altered calcium signalling following muscle-408 
specific RANK deletion impairs mitochondrial function given the well-established role of the 409 
calcium-dependent effectors calcineurin and NFATc1 in enhancing muscle endurance and 410 
mitochondrial respiratory capacity (21). Nevertheless, our findings indicate that RANK 411 
deletion enhances force production, promotes a fast-twitch phenotype and fatigability while 412 
increasing stim1 content and decreasing SERCA activity. 413 
 414 
Perspective and conclusion 415 
 Osteoporosis and muscle wasting occur simultaneously in a variety of pathologies, 416 
although common signalling pathways between these two processes were not identified (Fig. 417 
6). Here, we show that in addition to its role in bone homeostasis, RANK signalling also 418 
regulates Ca2+ storage, muscle mass, and muscle performance. Muscle-specific deletion of 419 
RANK has an inotropic effect on denervated fast-twitch EDL muscles, largely composed of 420 
type IIA, IIX, and IIB fibers. Fast-twitch fibers are usually the first to be affected in several 421 
forms of muscular and neuromuscular diseases and aging conditions, leading to premature 422 
loss of function and important incapacities (8). Our findings show for the first time that fast-423 
twitch fibers may be specifically targeted to enhance their force production. Although these 424 
results are preliminary and the long-term effects remain to be determined, this discovery 425 
opens a whole new field of research and new therapeutics avenues for conditions affecting in 426 
synchrony bone and skeletal muscle and potentially heart diseases.  427 
  428 
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Table caption 617 
Table 1: Body weights and muscle mass normalized to body weight of mice. 618 
Denervation and/or muscle RANK deletion did not influence body weight. Treatment, but 619 
not genotype, reduced EDL and Sol muscle mass normalized to body weight. Data are 620 
presented as mean +/- SEM, n=7. The level of significance was set at # p<0.05 for treatment 621 
(Sham vs Den). 622 
 623 
Table 2: Contractile properties of Sol and EDL muscles. Ctr, sham and denervated 624 
RANKf/f  and RANKmko SOL and EDL muscles were incubated ex vivo and electrically 625 
stimulated to record maximal absolute force (P0) and twitch tension Pt (g). P0 (g) decreased 626 
independently of genotype following denervation. However, muscle RANK deletion 627 
prevented the loss of twitch force in denervated EDL muscles. No difference in P0 and Pt 628 
were observed in muscle RANK deletion of control mice. Data are presented as mean +/- 629 
SEM, n=7. The level of significance was set at # p<0.05 for treatment (Sham vs Den). 630 
  631 
 632 
 633 
 634 
 635 
 636 
 637 
 638 
 639 
 640 
 641 
 642 
 643 
 644 
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Figure caption 645 
Figure 1: RANK expression in skeletal muscles and myotubes. (a) Western blot showing 646 
that fully differentiated C2C12 myotubes but not myoblasts express RANK protein. GAPDH 647 
is shown as a loading control (b) Confocal images showing colocalization of intracellular 648 
face of cytoplasmic membrane/sarcolemma dystrophin (green) and RANK (red) in RANKf/f 649 
and the absence of RANK in RANKmko EDL muscles. Thymus sections were used as positive 650 
controls for RANK immunofluorescence. Omission of primary antibody was used as a 651 
negative control. Because non muscle cells in skeletal muscles can also express RANK, 652 
confocal images, rather than Western blots, were required to confirm the absence of muscle 653 
RANK in RANKmko mice. Bar =100 m. (c) PCR analysis of genomic DNA isolated from 654 
Sol muscle, EDL muscle, heart, liver, spleen and kidney showing efficient Cre-mediated 655 
recombination of loxP sites in skeletal muscles from RANKmko mice. 656 
 657 
Figure 2: Impact of RANK deletion on muscle contractility, fatigue and phenotype. (a) 658 
Muscle atrophy was significantly more pronounced in denervated RANKmko relative to 659 
RANKf/f EDL muscles. (b) However, ex vivo force measurements show that RANK ablation 660 
preserves the specific force tension of denervated (Den) EDL muscles but not in slow-twitch 661 
Sol muscles. (c) RANK deletion increases Pt/P0 ratio in Sol and EDL muscles following 662 
denervation. (d) Muscle glycolytic fatigue protocol was induced by a train of stimulations 663 
(200 ms on: 800 ms off, 50 Hz) until Sol muscles force reach 70% of its initial force. Fatigue 664 
time is decreased in denervated muscle but similar between RANKf/f and RANKmko muscles. 665 
(e) Muscle glycolytic fatigue protocol was induced by a train of stimulations (200 ms on: 800 666 
ms off, 50 Hz) until EDL muscles force reach 50% of its initial force. Sham and denervated 667 
RANKmko EDL muscles exhibit increased fatigability compared to sham and denervated 668 
RANKf/f EDL muscles. (f) Fiber typing of EDL muscle analysis showed that the slow-twitch 669 
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fibers were nearly absent in sham RANKmko EDL muscles while the proportion of fast-twitch 670 
fibers (IIA+IIB+IIX) was significantly increased in denervated RANKmko EDL muscles 671 
compared to denervated RANKf/f EDL muscles. The levels of significance were set at * 672 
p<0.05, ** p<0.01, *** p<0.001 for genotype (Rankf/f vs Rankmko) or # p<0.05 for treatment 673 
(Sham vs Den). Data are presented as mean +/- SEM, n = 3-7. 674 
 675 
Figure 3: Percentage of type I and II fibers in Sol muscles and proportion of each fiber 676 
type expressing SERCA-1a and SERCA-2a in Sol and EDL muscles. (a) As opposed to 677 
fast-twitch EDL muscles, no changes in phenotype were observed in sham or denervated 678 
RANKf/f  and RANKmko in Sol muscles. (b) Sham and denervated RANKmko muscles 679 
exhibited a lower proportion of fast-twitch fibers expressing SERCA-1a and a higher 680 
proportion of fast-twitch fibers expressing SERCA-2a. The levels of significance were set at 681 
* p<0.05, ** p<0.01, *** p<0.001 for genotype (Rankf/f vs Rankmko) or # p<0.05 for 682 
treatment (Sham vs Den). Data are presented as mean +/- SEM, n = 6-8. 683 
   684 
Figure 4: Total calcium content, SERCA activity and calcium protein contents in 685 
RANKf/f and RANKmko EDL muscles. (a-c) [CaT] was decreased in sham RANKmko EDL 686 
muscles relative to sham RANKf/f  EDL muscles but increased sharply in denervated 687 
RANKmko EDL muscles. (d) Western blots show that SERCA-1a content is reduced while 688 
SERCA-2a content is increased following denervation. No changes in calsequestrin content 689 
were observed, but Stim1 content increased markedly in denervated RANKmko EDL muscles. 690 
(e) SERCA Ca2+-dependent ATPase activity was assessed in muscle homogenates from sham 691 
and denervated RANKf/f and RANKmko EDL muscles over Ca2+ concentrations ranging from 692 
pCa 7.4 to pCa5.0 (f) maximal ATPase activity (Vmax) and (g) pCa value required to elicit 693 
50% of maximal activity (pCa50). The levels of significance were set at * p<0.05, ** p<0.01, 694 
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*** p<0.001 for genotype (Rankf/f vs Rankmko) or # p<0.05 for treatment (Sham vs Den). 695 
Data are presented as mean +/- SEM, n = 3-7. 696 
 697 
Figure 5: SERCA Ca2+-dependent ATPase parameters from sham and denervated 698 
RANKf/f and RANKmko in Sol muscles. Denervation induced a significant reduction of (a) 699 
SERCA Ca2+ dependent ATPase activity and Vmax (b) maximal ATPase activity (Vmax) (c) 700 
pCa value required to elicit 50% of maximal activity (pCa50) were similar between control 701 
and experimental Sol muscles. The level of significance between genotype (Rankf/f/Rankmko) 702 
was set at * p<0.05, ** p<0.01, *** p<0.001 and set at # p<0.05 between treatment 703 
(Sham/Den). Data are presented as mean +/- SEM, n = 3-7. 704 
 705 
Figure 6: Schematic representation of RANK/RANKL/OPG pathway as common 706 
regulator of bone and muscle cells. In osteoclast, RANK/RANKL interaction regulates 707 
osteoclastogenesis and/or cell apoptosis through modulation of SERCA activity, Ca2+ 708 
oscillation, Ca2+-calcineurin-NFAT and NF-kB pathways. Muscle cells also express RANK 709 
and RANK/RANKL interaction is an important regulator of SERCA activity, calcium storage 710 
in fast-twitch EDL muscles. These results highlight the importance of a common signalling 711 
pathway opening potentially new treatment for both skeletal muscle and bone. 712 
 713 
 714 
 715 
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Table 1  
 Mice 
Shamf/f Denf/f Shammko Denmko 
Body 
weight (g) 
24.7 
± 
0.8 
24.3 
± 
0.7 
23.8 
± 
1.4 
24.5 
± 
1.9 
EDL 
muscle 
weight / 
Body 
weight 
0,34  
±  
0,05 
0,28 #  
±  
0,02 
 
0,38  
±  
0,04 
0,25 # 
±  
0,04 
Sol muscle 
weight / 
Body 
weight 
0,29  
± 
0,04 
0,24 # 
±  
0,03 
0,26  
±  
0,03 
0,23 # 
±  
0,04 
 
 
 
 
  Table 2 
 Sol EDL 
Ctrf/f Shamf/f Denf/f Ctrmko Shammko Denmko Ctrf/f Shamf/f Denf/f Ctrmko Shammko Denmko 
P0 
(g) 
26.6 
± 
1.2 
 
26.1 
± 
0.6 
19.6# 
± 
0.4 
26.9 
± 
1.5 
25.6 
± 
1.4 
18.1# 
± 
1.8 
33.5 
± 
1.7 
33.1 
± 
1.6 
21.3# 
± 
1.4 
32.7 
± 
1.8 
33.5 
± 
1.3 
22.1# 
± 
1.4 
Pt 
(g) 
3.8 
± 
0.6 
4.3 
± 
0.2 
4.2 
± 
0.3 
4.8 
± 
0.5 
4.3 
± 
0.4 
4.9 
± 
0.4 
7.1 
± 
0.6 
7.5 
± 
0.8 
5.6# 
± 
0.5 
5.3 
± 
0.6 
5.8 
± 
0.8 
6.2 
± 
0.4 
 
 
 
 






